Bevacizumab in clinical practice: prescribing appropriateness relative to national indications and safety.
about
Off-label use of targeted therapies in oncologyAngiogenic inhibitors for older patients with advanced colorectal cancer: does the age hold the stage?Is there such a thing as a cancer treatment that isn't worth its cost?Influence of the American ODAC statement on Austrian bevacizumab prescribing practice for metastatic breast cancer.Targeted therapies in colorectal cancer-an integrative view by PPPMTrastuzumab-related cardiotoxicity in early breast cancer: a cohort studyMolecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment.Complications of oncologic therapy in the abdomen and pelvis: a review.Off-label drug use in oncology: a systematic review of literature.Overuse in cancer care: do European studies provide information useful to support policies?Best Practices in Treatment Selection for Patients With Advanced NSCLC.
P2860
Q26747685-C39B98F9-3A1C-420C-8C50-746666AB8CF0Q27002538-C921DFCC-EF68-40C6-848E-21160A5C30BAQ35705230-93580E26-1D32-40CB-A55E-275930715D4DQ36102859-6D72EFAD-A466-4E6F-8A33-7B2DB75F9917Q36646911-C3203DB9-8BE7-477C-ACE4-7433195ABBEDQ37038459-5B8ACE82-409C-4AE6-8BB5-9DCC5DC3C804Q37581359-EAAF1CD4-58D6-4473-9460-AFD0DAA31721Q38014349-A7CAA279-B79A-460B-8A3C-1B1B7C5CD667Q38977535-2B81B5AF-CFB9-46D6-9ABC-FFF348EDBA63Q49843226-E4F10032-3CAB-4200-8027-2FADA5DC0D58Q52814108-75E85D7E-9380-40D3-AD58-BF60696C4153
P2860
Bevacizumab in clinical practice: prescribing appropriateness relative to national indications and safety.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Bevacizumab in clinical practi ...... tional indications and safety.
@ast
Bevacizumab in clinical practi ...... tional indications and safety.
@en
type
label
Bevacizumab in clinical practi ...... tional indications and safety.
@ast
Bevacizumab in clinical practi ...... tional indications and safety.
@en
prefLabel
Bevacizumab in clinical practi ...... tional indications and safety.
@ast
Bevacizumab in clinical practi ...... tional indications and safety.
@en
P2093
P2860
P50
P1433
P1476
Bevacizumab in clinical practi ...... tional indications and safety.
@en
P2093
Carlo Zocchetti
Marta Rossi
Martina Bonifazi
Matteo Franchi
Vincenzo Davide Scigliano
P2860
P304
P356
10.1634/THEONCOLOGIST.2011-0184
P577
2011-12-30T00:00:00Z